Detalles de la búsqueda
1.
Impact of combined lipid lowering and blood pressure control on coronary plaque: myocardial ischemia treated by percutaneous coronary intervention and plaque regression by lipid lowering and blood pressure controlling assessed by intravascular ultrasonography (MILLION) study.
Heart Vessels;
32(5): 539-548, 2017 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-27798731
2.
Efficacy and Safety of Alirocumab in Japanese Patients With Heterozygous Familial Hypercholesterolemia or at High Cardiovascular Risk With Hypercholesterolemia Not Adequately Controlled With Statinsã- ODYSSEY JAPAN Randomized Controlled Trial.
Circ J;
80(9): 1980-7, 2016 Aug 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-27452202
3.
Impact of combined lipid lowering with blood pressure control on coronary plaque regression: rationale and design of MILLION study.
Heart Vessels;
30(5): 580-6, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-24895097
4.
Large-cell Neuroendocrine Carcinoma of the Lung with Carcinoid Syndrome.
Intern Med;
62(10): 1557-1563, 2023 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-36198589
5.
CORRIGENDUM: Efficacy and Safety of Alirocumab in Japanese Patients With Heterozygous Familial Hypercholesterolemia or at High Cardiovascular Risk With Hypercholesterolemia Not Adequately Controlled With Statinsã- ODYSSEY JAPAN Randomized Controlled Trial.
Circ J;
80(11): 2414, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27784878
6.
A case with familial hypercholesterolemia complicated with severe systemic atherosclerosis intensively treated for more than 30 years.
J Cardiol Cases;
22(5): 216-220, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-33133313
7.
Hokuriku-plus familial hypercholesterolaemia registry study: rationale and study design.
BMJ Open;
10(9): e038623, 2020 09 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32912992
8.
Limited effects of long-term enzyme replacement therapy on the cardiac conduction system in Fabry disease.
J Cardiol Cases;
17(5): 178-181, 2018 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-30279886
9.
Acute necrotizing eosinophilic myocarditis complicated by complete atrioventricular block promptly responded to glucocorticoid therapy.
J Cardiol Cases;
16(1): 5-8, 2017 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-30279784
10.
Impact of evolocumab treatment on low-density lipoprotein cholesterol levels in heterozygous familial hypercholesterolemic patients withdrawing from regular apheresis.
Atherosclerosis;
265: 225-230, 2017 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-28926730
11.
Cholesterol-years score is associated with development of senile degenerative aortic stenosis in heterozygous familial hypercholesterolemia.
J Atheroscler Thromb;
13(6): 323-8, 2006 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-17192697
12.
Long-term course of lipoprotein lipase (LPL) deficiency due to homozygous LPL(Arita) in a patient with recurrent pancreatitis, retained glucose tolerance, and atherosclerosis.
J Clin Endocrinol Metab;
90(12): 6541-4, 2005 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-16174715
13.
Cutoff point separating affected and unaffected familial hypercholesterolemic patients validated by LDL-receptor gene mutants.
J Atheroscler Thromb;
12(1): 35-40, 2005.
Artículo
en Inglés
| MEDLINE | ID: mdl-15725694
14.
Reduction of serum ubiquinol-10 and ubiquinone-10 levels by atorvastatin in hypercholesterolemic patients.
J Atheroscler Thromb;
12(2): 111-9, 2005.
Artículo
en Inglés
| MEDLINE | ID: mdl-15942122
15.
Association of estrogen receptor-alpha gene polymorphisms with coronary artery disease in patients with familial hypercholesterolemia.
Arterioscler Thromb Vasc Biol;
22(5): 817-23, 2002 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-12006396
16.
Haplotype analyses of cholesteryl ester transfer protein gene promoter: a clue to an unsolved mystery of TaqIB polymorphism.
J Mol Med (Berl);
81(4): 246-55, 2003 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-12700892
17.
Molecular genetic analysis of familial hypercholesterolemia: spectrum and regional difference of LDL receptor gene mutations in Japanese population.
Atherosclerosis;
165(2): 335-42, 2002 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-12417285
18.
Long-term treatment with pitavastatin (NK-104), a new HMG-CoA reductase inhibitor, of patients with heterozygous familial hypercholesterolemia.
Atherosclerosis;
163(1): 157-64, 2002 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-12048134
19.
Clinical efficacy and safety of rosuvastatin in Japanese patients with heterozygous familial hypercholesterolemia.
J Atheroscler Thromb;
11(3): 152-8, 2004.
Artículo
en Inglés
| MEDLINE | ID: mdl-15256766
20.
Detailed analysis of serum lipids and lipoproteins from Japanese type III hyperlipoproteinemia with apolipoprotein E2/2 phenotype.
Clin Chim Acta;
348(1-2): 35-40, 2004 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-15369733